Prognostic role of CD4 T-cell depletion after frontline fludarabine, cyclophosphamide and rituximab in chronic lymphocytic leukaemia. [electronic resource]
Producer: 20200108Description: 809 p. digitalISSN:- 1471-2407
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- CD4-Positive T-Lymphocytes -- drug effects
- Cyclophosphamide -- adverse effects
- Female
- Follow-Up Studies
- Humans
- Immunoglobulin Variable Region -- genetics
- Immunosuppressive Agents -- adverse effects
- Leukemia, Lymphocytic, Chronic, B-Cell -- diagnosis
- Lymphocyte Count
- Male
- Middle Aged
- Mutation
- Neoplasm, Residual
- Prognosis
- Rituximab -- adverse effects
- Survival Analysis
- Treatment Outcome
- Vidarabine -- adverse effects
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.